Bluejay Diagnostics Inc (NASDAQ:BJDX) price on current trading day, rose 3.14% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.97.
A look at the stock’s price movement, the level at last check in today’s session was $1.91, moving within a range at $1.88 and $2.08. The beta value (5-Year monthly) was 0.349. Turning to its 52-week performance, $316.92 and $1.46 were the 52-week high and 52-week low respectively. Overall, BJDX moved -45.58% over the past month.
Bluejay Diagnostics Inc’s market cap currently stands at around $2.94 million, with investors looking forward to this quarter’s earnings report slated for on 2024-Mar-27.
Turning to the stock’s technical picture we see that short term indicators suggest on average that BJDX is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend BJDX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
BJDX’s current price about -20.74% and -41.33% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 42.26, while 7-day volatility ratio is 17.85% and 21.28% in the 30-day chart. Further, Bluejay Diagnostics Inc (BJDX) has a beta value of 0.40, and an average true range (ATR) of 0.58.
If we refocus on Bluejay Diagnostics Inc (NASDAQ:BJDX), historical trading data shows that trading volumes averaged 0.31 over the past 10 days and 1.16 million over the past 3 months. The company’s latest data on shares outstanding shows there are 0.55 million shares.
The 0.29% of Bluejay Diagnostics Inc’s shares are in the hands of company insiders while institutional holders own 0.45% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 38307.0 on 2025-04-15, giving us a short ratio of 0.01. The data shows that as of 2025-04-15 short interest in Bluejay Diagnostics Inc (BJDX) stood at 310.0 of shares outstanding, with shares short rising to 6002.0 registered in 2025-03-14. Current price change has pushed the stock -59.55% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the BJDX stock continues to rise going into the next quarter.
